Venetoclax/decitabine for a pediatric patient with chronic myelomonocytic leukemia-Reference-Cited by-同舟云学术

Venetoclax/decitabine for a pediatric patient with chronic myelomonocytic leukemia

Published:2020-12-27 Issue:3 Volume:68 Page:
ISSN:1545-5009
Container-title:Pediatric Blood & Cancer
language:en
Short-container-title:Pediatr Blood Cancer

Author:

Molina John C.¹²^ORCID,Asare Julie M.²,Tuschong Laura³,West Robert R.³,Calvo Katherine R.⁴,Persky Rebecca⁵⁶,Boyce Alison M.⁷,Hammoud Dima A.⁸,Holland Steven M.⁹,Hickstein Dennis³^ORCID,Shah Nirali N.¹^ORCID

Affiliation:

1. Pediatric Oncology Branch Center for Cancer Research (CCR) National Cancer Institute (NCI) NIH Bethesda Maryland

2. Department of Pediatric Oncology Johns Hopkins Hospital Baltimore Maryland

3. Immune Deficiency‐Cellular Therapy Program Center for Cancer Research, National Cancer Institute Bethesda Maryland

4. Department of Laboratory Medicine NIH Clinical Center Bethesda Maryland

5. National Institute of Child Health and Human Development NIH Bethesda Maryland

6. Department of Pediatric Endocrinology Children's National Medical Center Washington District of Columbia

7. Skeletal Disorders and Mineral Homeostasis Section National Institute of Dental and Craniofacial Research NIH Bethesda Maryland

8. Center for Infectious Disease Imaging (CIDI) Radiology and Imaging Sciences NIH Clinical Center Bethesda Maryland

9. Immunopathogenesis Section National Institute of Allergy and Infectious Diseases NIH Bethesda Maryland

Publisher

Wiley

Subject

Oncology,Hematology,Pediatrics, Perinatology and Child Health

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/pbc.28865

Reference31 articles.

1. How I treat chronic myelomonocytic leukemia

2. Erratum: Chronic myelomonocytic leukemia in younger patients: molecular and cytogenetic predictors of survival and treatment outcome

3. Chronic myelomonocytic leukemia: 2020 update on diagnosis, risk stratification and management;Patnaik MM;Am J Hematol,2019

4. Acute myeloid leukemia with central diabetes insipidus

5. Safety and preliminary efficacy of venetoclax with decitabine or azacitidine in elderly patients with previously untreated acute myeloid leukaemia: a non-randomised, open-label, phase 1b study

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Venetoclax: a new player in the treatment of children with high-risk myeloid malignancies?;Blood Advances;2024-07-09

2. Recent Updates in Venetoclax Combination Therapies in Pediatric Hematological Malignancies;International Journal of Molecular Sciences;2023-11-24

3. The spectrum of GATA2 deficiency syndrome;Blood;2023-03-30

4. Targeted Epigenetic Interventions in Cancer with an Emphasis on Pediatric Malignancies;Biomolecules;2022-12-28

5. ASXL1 and STAG2 are common mutations in GATA2 deficiency patients with bone marrow disease and myelodysplastic syndrome;Blood Advances;2022-01-31